Dermatology News

Dermatology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Galadari H et al. - The authors report a 48-year-old man with skeletal and cutaneous signs and symptoms who improved dramatically after treatment with a combination of isotretinoin and pamidronate. This report provides an alternative treatment regimen for SAPHO that addresses the possible underlying pathophysiology of this likely underdiagnosed syndrome.

Related Articles

Long-Term Effects of Pamidronate in Thalassemic Patients with Severe Bone Mineral Density Deficits
Hemoglobin, 10/23/09    Relevance Score: 82%

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Journal of Clinical Oncology, 10/12/09    Relevance Score: 77%

Today in Clinical Pharmacology...keeping you current

Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09

Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview
Journal of the European Academy of Dermatology and Venereology, 12/03/09

Dermatomyositis: current and future treatments
Expert Review of Dermatology, 12/03/09